Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

GEN

Gen Digital (GEN)

Gen Digital Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GEN
FechaHoraFuenteTítuloSímboloCompañía
10/12/202416:25PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of MoneyLion Inc.NASDAQ:GENGen Digital Inc
10/12/202415:08Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GENGen Digital Inc
10/12/202407:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GENGen Digital Inc
10/12/202407:00PR Newswire (US)Gen Extends its Financial Wellness Offerings with the Acquisition of MoneyLionNASDAQ:GENGen Digital Inc
04/12/202408:00PR Newswire (US)Gen Reveals Cybersecurity Predictions for 2025NASDAQ:GENGen Digital Inc
03/12/202415:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GENGen Digital Inc
26/11/202415:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GENGen Digital Inc
21/11/202410:30PR Newswire (US)Norton Introduces Small Business Premium for Powerful, Easy-to-Use Business-Grade SecurityNASDAQ:GENGen Digital Inc
19/11/202408:00PR Newswire (US)Gen Q3 Threat Report: Millions Fooled by "Scam-Yourself Attacks"NASDAQ:GENGen Digital Inc
06/11/202410:01GlobeNewswire Inc.Genmab Announces Financial Results for the First Nine Months of 2024NASDAQ:GENGen Digital Inc
31/10/202416:27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GENGen Digital Inc
31/10/202415:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GENGen Digital Inc
30/10/202415:05PR Newswire (US)Gen Reports Second Quarter Fiscal Year 2025 ResultsNASDAQ:GENGen Digital Inc
29/10/202402:01PR Newswire (US)Don't Let Scammers Steal Your Holiday Cheer: New Norton Report Reveals Nearly Half of U.S. Consumers Were Targeted by a Scam While Online ShoppingNASDAQ:GENGen Digital Inc
17/10/202415:00PR Newswire (US)Election Scams on the Rise: Over Half of Americans Targeted with Election ScamsNASDAQ:GENGen Digital Inc
15/10/202405:25GlobeNewswire Inc.Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024NASDAQ:GENGen Digital Inc
08/10/202415:05PR Newswire (US)Gen to Announce Fiscal 2025 Second Quarter Results on October 30, 2024NASDAQ:GENGen Digital Inc
04/10/202412:55GlobeNewswire Inc.Major Shareholder AnnouncementNASDAQ:GENGen Digital Inc
24/09/202410:00PR Newswire (US)Norton Benefit Solutions Expands Global OfferingNASDAQ:GENGen Digital Inc
19/09/202407:00PR Newswire (US)AARP Services Announces New Enhanced Offerings for AARP Members This FallNASDAQ:GENGen Digital Inc
13/09/202415:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:GENGen Digital Inc
04/09/202408:00PR Newswire (US)Multi-million-dollar Deepfake Campaigns Blocked by GenNASDAQ:GENGen Digital Inc
21/08/202408:00PR Newswire (US)Parents Cautiously Optimistic on AI in Schools: Content Safety and Data Privacy Among Top WorriesNASDAQ:GENGen Digital Inc
19/08/202413:00GlobeNewswire Inc.TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular LymphomaNASDAQ:GENGen Digital Inc
08/08/202410:03GlobeNewswire Inc.Genmab Announces Financial Results for the First Half of 2024NASDAQ:GENGen Digital Inc
08/08/202410:00GlobeNewswire Inc.Genmab Updates 2024 Financial GuidanceNASDAQ:GENGen Digital Inc
06/08/202408:00PR Newswire (US)New LifeLock Scan Tool Reveals Our Data is 'Out of Control'NASDAQ:GENGen Digital Inc
05/08/202404:50GlobeNewswire Inc.Genmab Takes Full Control of Acasunlimab Development ProgramNASDAQ:GENGen Digital Inc
01/08/202415:05PR Newswire (US)Gen Reports First Quarter Fiscal Year 2025 ResultsNASDAQ:GENGen Digital Inc
30/07/202411:00PR Newswire (US)New Norton VPN Lineup Delivers Ultra ProtectionNASDAQ:GENGen Digital Inc
 Showing the most relevant articles for your search:NASDAQ:GEN